New Delhi: The first nasal vaccine for COVID-19 developed by Bharat Biotech has received regulatory approval for Phase II and III clinical trials. The...
Beijing: China's declining population remains a matter of concern. Recently, Chinese officials were quoted as saying that the population crisis in China is worse...
New Delhi: The Union Public Service Commission (UPSC) has announced a rescheduling of the Civil Services Examination (Preliminary) for the year 2024. Initially set...